| Literature DB >> 33296423 |
Carlos López-de-Celis1,2, Albert Pérez-Bellmunt1, Elena Bueno-Gracia3, Pablo Fanlo-Mazas3, Carlos Antonio Zárate-Tejero1, Luis Llurda-Almuzara1, Aida Cadellans Arróniz1, Pere Ramón Rodriguez-Rubio1.
Abstract
Diacutaneous fibrolysis is a noninvasive technique that has been shown to be effective in the treatment of musculoskeletal disorders such as shoulder pain, lateral epicondylalgia, patellofemoral pain syndrome and carpal tunnel syndrome. However, while diacutaneous fibrolysis is applied to soft tissue, its effects on muscular properties are unknown. The purpose of the present study was to evaluate the effects of diacutaneous fibrolysis on muscle properties as measured by tensiomyography and myotonometry in asymptomatic subjects. An analytical descriptive study was performed. A single session of diacutaneous fibrolysis on the gastrocnemius muscle was applied to one limb (treated limb group) and the other limb was the control (control limb group). Subjects were assessed with tensiomyography and myotonometry before treatment (T0), after treatment (T1) and 30 minutes later (T2). The primary outcomes were tensiomyography and myotonometry variables. The treated limb group showed a statistically significant increase (p<0.05) in tensiomyography parameters. A decrease in rigidity and increase in relaxation was also observed on myotonometry at T1, with some of the effects being maintained at T2. Rigidity and relaxation at T1 were statistically significant between groups (p<0.05). A single session of diacutaneous fibrolysis to the gastrocnemius muscle of asymptomatic subjects produced immediate changes in muscle properties. These changes were maintained 30 minutes after the application of the technique.Entities:
Mesh:
Year: 2020 PMID: 33296423 PMCID: PMC7725309 DOI: 10.1371/journal.pone.0243225
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Measurement procedures.
A: Myotonometry; B: Tensiomyography.
Fig 2Application of diacutaneous fibrolysis on gastrocnemius muscle.
Outcome variable values, intra-group analysis.
| T0 | T1 | T2 | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | End of treatment | Difference from baseline | 30’ Post-treatment | Difference from baseline | ||||
| Mean ± SD | Mean ± SD | Mean (95% CI) | p-value | Mean ± SD | Mean (95% CI) | p-value | ||
| Tc (ms) | 30.02 ± 9.92 | 39.75 ± 12.73 | 10.17 (5.07/15.28) | 0.001 | 37.67 ± 12.90 | 8.06 (2.61/13.52) | 0.002 | |
| Td (ms) | 21.35 ± 1.85 | 22.77 ± 1.77 | 1.46 (0.83/2.09) | 0.001 | 23.28 ± 2.11 | 2.02 (1.22/2.83) | 0.001 | |
| Tr (ms) | 61.06 ± 19.42 | 64.05 ± 29.63 | 3.99 (-9.97/17.95) | n.s. | 63.29 ± 24.64 | 3.28 (-7.99/14.56) | n.s. | |
| Dm (ms) | 4.40 ± 1.73 | 4.82 ± 1.73 | 0.48 (0.08/0.88) | 0.014 | 4.75 ± 1.60 | 0.43 (-0.08/0.94) | n.s. | |
| Ts (ms) | 220.52 ± 54.91 | 227.81 ± 49.91 | 6.06 (-12.60/24.73) | n.s. | 236.86 ± 42.60 | 15.17 (-11.54/41.89) | n.s. | |
| Tone | 14.97 ± 1.42 | 14.52 ± 1.23 | -0.45 (-0.68/-0.23) | 0.001 | 14.67 ± 1.30 | -0.30 (-0.58/-0.03) | 0.028 | |
| Stiffness | 257.89 ± 30.01 | 248.17 ± 26.20 | -9.72 (-13.90/-5.72) | 0.001 | 250.17 ± 26.25 | -7.72 (-12.49/-2.95) | 0.001 | |
| Relaxation | 21.90 ± 2.60 | 22.45 ± 2.23 | 0.55 (0.05/1.04) | 0.026 | 22.08 ± 2.11 | 0.18 (-0.37/0.73) | n.s. | |
| Tc (ms) | 31.10 ± 11.21 | 34.63 ± 13.16 | 3.91 (-0.66/8.49) | n.s. | 37.49 ± 11.62 | 6.84 (1.58/12.09) | 0.008 | |
| Td (ms) | 22.98 ± 6.65 | 22.89 ± 2.28 | 0.00 (-3.11/3.11) | n.s. | 23.26 ± 2.49 | 0.38 (-2.25/2.98) | n.s. | |
| Tr (ms) | 56.81 ± 25.09 | 61.96 ± 30.65 | 6.01 (-8.77/20.78) | n.s. | 68.93 ± 30.25 | 12.42 (-2.61/27.44) | n.s. | |
| Dm (ms) | 4.37 ± 1.59 | 4.62 ± 1.46 | 0.30 (-0.19/0.80) | n.s. | 4.75 ± 1.32 | 0.43 (-0.05/0.91) | n.s. | |
| Ts (ms) | 204.32 ± 42.20 | 226.80 ± 55.60 | 21.67 (-0.22/43.56) | n.s. | 230.26 ± 35.47 | 25.02 (10.69/39.34) | 0.001 | |
| Tone | 15.03 ± 1.51 | 14.74 ± 1.52 | -0.29 (-0.64/0.54) | n.s. | 14.72 ± 1.48 | -0.02 (-0.65/0.02) | n.s. | |
| Stiffness | 257.05 ± 30.60 | 255.56 ± 27.34 | -1.48 (-5.28/2.31) | n.s. | 252.91 ± 27.47 | -4.14 (-9.62/1.34) | n.s. | |
| Relaxation | 21.73 ± 2.39 | 21.92 ± 2.12 | 0.19 (-0.20/0.57) | n.s. | 21.85 ± 2.28 | 0.12 (-0.430/0.67) | n.s. | |
Abbreviations: n.s., not significant; SD, standard deviation. Tc, contraction time; Td, delay time; Tr, half-relaxation time; Dm, maximal displacement; Ts, sustained time; p-value: Repeated measures ANOVA and Bonferroni post hoc test.
* p-value: Friedman test and Wilcoxon post hoc test.
Outcome variable values, inter-group analysis: Treated limb vs untreated limb.
| T1 | T2 | |||
|---|---|---|---|---|
| Difference from baseline | Difference from baseline | |||
| Mean (95%CI) | p-value | Mean (95% CI) | p-value | |
| 6.27 (1.19/11.33) | 0.017 | 1.23 (-3.69/6.15) | n.s. | |
| 1.47 (-0.99/3.93) | n.s. | 1.66–0.71/4.02) | n.s. | |
| -2.02 (-20.57/16.53) | n.s. | -9.13 (-21.99/3.73) | n.s. | |
| 0.18 (-0.29/0.65) | n.s. | -0.01 (-0.40/0.39) | n.s. | |
| -15.61 (-37.08/5.87) | n.s. | -9.85 (-34.07/14.37) | n.s. | |
| -0.16 (-0.44/0.12) | n.s. | 0.01 (-0.24/0.27) | n.s. | |
| -8.23 (-10.96/-5.51) | 0.001 | -3.58 (-7.27/0.11) | n.s. | |
| 0.36 (0.03/0.69) | 0.032 | 0.06 (-0.36/0.48) | n.s. | |
Abbreviations: n.s., not significant; SD, standard deviation; Tc, contraction time; Td, delay time; Tr, half-relaxation time; Dm, maximal displacement; Ts, sustained time; p-value: Paired t test.
* p-value with Wilcoxon test.